Drug Concentration, Immunogenicity, and Efficacy Study in Patients With Rheumatoid Arthritis Currently Treated With Etanercept, Adalimumab, or Infliximab
Clinical trial NCT01981473 · COMPLETED
Trial details
- NCT number
- NCT01981473
- Sponsor
- Pfizer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2014-01-01
- Primary completion
- 2014-12-01
- Enrollment
- 605
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.